Review: SSRIs and TCAs equally effective at treating chronic depression and dysthemia; SSRIs are associated with fewer adverse events than TCAs. uri icon

Overview

publication date

  • April 20, 2013

Research

keywords

  • Antidepressive Agents, Tricyclic
  • Depressive Disorder
  • Dysthymic Disorder
  • Selective Serotonin Reuptake Inhibitors

Identity

Scopus Document Identifier

  • 84880054693

Digital Object Identifier (DOI)

  • 10.1136/eb-2013-101268

PubMed ID

  • 23604275

Additional Document Info

volume

  • 16

issue

  • 3